John D. "Jack" Hogoboom, Partner - Capital Markets & Securities, New York

New York / New Jersey

T: +1 646.414.6846 | F: +1 973.597.2383 jhogoboom@lowenstein.com

New York / New Jersey

T: +1 646.414.6846 | F: +1 973.597.2383 jhogoboom@lowenstein.com

Related Areas

Education

University of Pennsylvania Law School (J.D. 1985), cum laude; Editor, University of Pennsylvania Law Review

Wharton School, University of Pennsylvania (B.S. 1982), magna cum laude

Admissions

New York
New Jersey

BIO
EXPERIENCE
HONORS & AWARDS
NEWS & INSIGHTS

Filter By

Section

Type:

Practices:

Sectors:

Start Date:

End Date:

Specializing in corporate finance and mergers and acquisitions, John Hogoboom ("Jack") has represented buyers, sellers, issuers, underwriters and investors in hundreds of transactions over his more than 35 years of practice. He has represented public and private clients in all types of transactions including IPOs, public and private domestic and cross-border offerings and public and private acquisitions in a wide range of industries including business services, consumer products, technology, life sciences, chemical, renewables, media and natural resources.

Jack has been listed in both the securities law and corporate law categories in The Best Lawyers in America since 2007. Often quoted in legal publications, he frequently publishes articles and speaks on corporate finance issues.

EXPERIENCE

Represented the Special Situations Funds, as the lead investors in the secondary purchase of Series A Convertible Preferred Stock of Bitcoin Depot Inc (NASDAQ: BTM).
Represented Big Rock Intermediate, LLC, a private-equity owned holding company specializing in serving the marketing needs of the franchising sector, in its acquisition of Fish Consulting, LLC, a Fort Lauderdale-based national communications firm.
Represented Special Situations Funds as lead investor in a $23 million registered direct offering of ordinary shares for Arbe Robotics Ltd. (NASDAQ: ARBE), a global leader in perception radar solutions.
Represented Wedbush Securities Inc. as sales agent for an at-the-market offering of common stock of TScan Therapeutics, Inc. (NASDAQ: TCRX), a clinical-stage biopharmaceutical company dedicated to creating life-changing T cell therapies, of up to $75 million.
Represented Ladenburg Thalmann & Co. Inc., B. Riley Securities, Inc. and Roth Capital Partners, LLC as sales agents in an At-The-Market sales agreement for the issuance of up to $100 million of common stock of Meta Materials Inc. (NASDAQ:MMAT)(FSE:MMAT), a developer of high-performance functional materials and nanocomposites.
Represented Ladenburg Thalmann & Co. Inc. and A.G.P./Alliance Global Partners as co-managing underwriters in a $25 million underwritten public offering of shares and warrants for Meta Materials Inc. (NASDAQ:MMAT)(FSE:MMAT), a developer of high-performance functional materials and nanocomposites.
Represented Big Rock Intermediate, LLC in its acquisition of the membership interests of Net Search Direct, LLC, a leads-driven digital marketing agency.
Represented Inspire Intermediate, LLC in its acquisition of the membership interests of iMemories LLC, a Scottsdale-based, cloud-based storage and streaming service.
Represented SmartKem Limited, a pioneer in the development of organic thin film transistors, in connection with its reverse acquisition of Parasol Investments Corp. and simultaneous private placement of $24.8 million of common stock and pre-funded warrants.
Represented Big Rock Parent, LLC, the parent of 919 Marketing Company, a content marketing firm, in connection with its acquisition of Ceralytics, LLC, a content intelligence platform.
Represented Greens Farms Capital in connection with its acquisition of 919 Marketing Company, LLC, a national content marketing firm.
Represented Zomedica Corp. (NYSE: ZOM), veterinary health company, in a $200 million underwritten offering of common shares.
Represented Zomedica Pharmaceuticals Corp. (NYSE: ZOM), a veterinary diagnostic and pharmaceutical company, in connection with a $30 million public offering of common stock and warrants.
Represented Roth Capital Partners and National Securities Corporation as joint book-running managers in connection with a $12.4 million underwritten offering of common stock and concurrent uplisting to the Nasdaq Capital Market of Flux Power Holdings, Inc. (NASDAQ: FLUX), a developer of advanced lithium industrial batteries for commercial and industrial equipment.
Represented Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, in a $22 million underwritten public offering of shares and warrants and subsequent uplisting to the Nasdaq Capital Market.
Represented Spring Bank Pharmaceuticals, Inc. (NASDQ: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, in a definitive share exchange agreement with F-star Therapeutics Limited, a privately-held clinical-stage biopharmaceutical company focused on transforming the lives of patients with cancer through the development of innovative tetravalent bispecific (mAb2™) antibodies.
Represented Special Situations Funds as lead investor in connection with a common stock PIPE for SharpSpring, Inc. (NASDAQ: SHSP), a leading cloud-based marketing automation platform for digital marketing agencies.
Represented National Securities Corporation as underwriter counsel in connection with a $21 million underwritten public offering of common shares of Oramed Pharmaceuticals Inc. (Nasdaq: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems.
Represented Special Situations Funds as lead investor in connection with a private placement of shares, warrants and pre-funded warrants of Ideal Power Inc. (NASDAQ: IPWR), a developer of innovative power conversion technologies.
Represented Oppenheimer & Co Inc. as sole placement agent in a registered direct offering of common stock and warrants for Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors.
Represented Zomedica Pharmaceuticals Corp. (NYSE: ZOM), a veterinary diagnostic and pharmaceutical company, in a follow-on underwritten offering.
Represented Roth Capital Partners in their role as sole placement agent in a registered direct offering for Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company based in Maryland.
Represented Oppenheimer & Co. Inc., as sole underwriter, in an underwritten public offering of Catabasis Pharmaceuticals, Inc. (Nasdaq: CATB).
Represented Special Situations Funds, as the lead investor, in a purchase and exchange transaction in which investors purchased all outstanding Series B Preferred Stock of Turtle Beach Corporation (Nasdaq: HEAR) with a market value of and exchanged them for common stock and pre-funded warrants.
Represented Roth Capital Partners, as underwriter and sole book-running manager, in a underwritten public offering for New Age Beverages Corporation (Nasdaq: NBEV).
Represented National Securities Corporation, as the sole book-running manager, and ROTH Capital Partners and Craig-Hallum Capital Group, as co-managers, in an initial public offering by Restoration Robotics, Inc. (NASDAQ: HAIR).
Represented Oppenheimer & Co. Inc. which acted as the representative for the initial purchasers in Akoustis Technologies, Inc.’s (NASDAQ: AKTS) Rule 144A offering of 6.5% Convertible Senior Secured Notes.
Represented Roth Capital Partners, LLC, as sales agent, in an at-the-market offering for Broadwind Energy, Inc. (Nasdaq:BWEN).
Represented lead investors in the sale of E Ink Corporation to Prime View.

HONORS & AWARDS

The Best Lawyers in America, published by Best Lawyers (2007-2024)
Recognized in the Corporate Law and Securities / Capital Markets Law sections

CLICK HERE FOR AWARD INFORMATION & METHODOLOGY

No aspect of these advertisements has been approved by the highest court of any state.

NEWS & INSIGHTS

Education

University of Pennsylvania Law School (J.D. 1985), cum laude; Editor, University of Pennsylvania Law Review

Wharton School, University of Pennsylvania (B.S. 1982), magna cum laude

Admissions

New York
New Jersey

Recent Searches

Relevant Insights

PROFESSIONALS | Lawyers

NEWS & INSIGHTS | Firm News

NEWS & INSIGHTS | Publications

Featured Content

LOWENSTEIN AI CHATBOT/ Version 1.0

PRO BONO / Report

FINTECH / Firm News

TRANSACTIONS & ADVISORY / Firm News

John D. "Jack" Hogoboom